After completing her masters studies at the University of Lisbon (Portugal), Lara Shahidian joined the Dacasto lab at the University of Padova (Italy) where she studied the potential use of G-quadruplex structures as targets for oncology treatment. She later joined the Schneider lab at the IGBMC (France), where she started her thesis entitled "The role of novel histone post-translational modifications in transcription". In June 2020, she obtained her PhD title from the Ludwig-Maximilians University Munich (Germany).
Lara joined the Rada-Iglesias lab at the IBBTEC (Spain) in November 2020 where she is currently studying the regulatory mechanism of poised enhancers.
The major interest of our laboratory is to uncover the main genetic and epigenetic factors that allow the deployment of specific gene expression profiles as vertebrate developmental programs unroll. Our goal is to provide a deep mechanistic understanding of the non-coding genomic space that is dynamically and specifically used during mammalian embryogenesis, which is fundamental to reveal the molecular basis of human congenital diseases. More specifically, by functionally and mechanistically characterizing developmental enhancers, my laboratory aims at:
Instituto de Biomedicina y Biotecnología de Cantabria.
PCTCAN - Cl. Albert Einstein, 22